(VLTO) Veralto - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US92338C1036
Stock:
Total Rating 46
Risk 91
Buy Signal 0.67
| Risk 5d forecast | |
|---|---|
| Volatility | 24.4% |
| Relative Tail Risk | -3.05% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.34 |
| Alpha | -18.45 |
| Character TTM | |
|---|---|
| Beta | 0.682 |
| Beta Downside | 0.327 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.73% |
| CAGR/Max DD | 0.29 |
EPS (Earnings per Share)
Revenue
Risks
Technicals:
low_hurst
Description: VLTO Veralto
Veralto Corporation provides water analytics, water treatment, marking and coding, and packaging and color solutions worldwide. It operates through two segments, Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment offers precision instrumentation and water treatment technologies to measure, analyze, and treat water in residential, commercial, municipal, industrial, research, and natural resource applications under the Hach, Trojan Technologies, ChemTreat, and other brands. This segment also provides water solutions, including chemical reagents, services, and digital solutions. The PQI segment offers marking and coding for packaged goods and related consumables; a software solution that provides digital asset management, marketing resource management, and product information management; inline printing solutions for products and packaging with marking and coding systems; design software and imaging systems for the creation of new packaging designs; color management solutions for printed packages and consumer and industrial products; and color standard services for the design industry. This segment sells its products and services through the Videojet, Linx, Esko, X-Rite, and Pantone brands. The company serves industries, such as municipal utilities, food and beverage, pharmaceutical, and industrials. The company was formerly known as DH EAS Holding Corp. and changed its name to Veralto Corporation in February 2023. Veralto Corporation was incorporated in 2022 and is headquartered in Waltham, Massachusetts.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 940.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 0.38 > 1.0 |
| NWC/Revenue: 25.00% < 20% (prev 21.99%; Δ 3.01% < -1%) |
| CFO/TA 0.14 > 3% & CFO 1.08b > Net Income 940.0m |
| Net Debt (642.0m) to EBITDA (1.35b): 0.48 < 3 |
| Current Ratio: 1.67 > 1.5 & < 3 |
| Outstanding Shares: last quarter (250.5m) vs 12m ago 0.08% < -2% |
| Gross Margin: 59.95% > 18% (prev 0.60%; Δ 5935 % > 0.5%) |
| Asset Turnover: 78.06% > 50% (prev 81.06%; Δ -3.00% > 0%) |
| Interest Coverage Ratio: 13.22 > 6 (EBITDA TTM 1.35b / Interest Expense TTM 96.0m) |
Altman Z'' 3.74
| A: 0.18 (Total Current Assets 3.43b - Total Current Liabilities 2.06b) / Total Assets 7.69b |
| B: 0.20 (Retained Earnings 1.52b / Total Assets 7.69b) |
| C: 0.18 (EBIT TTM 1.27b / Avg Total Assets 7.05b) |
| D: 0.68 (Book Value of Equity 3.11b / Total Liabilities 4.59b) |
| Altman-Z'' Score: 3.74 = AA |
Beneish M -3.04
| DSRI: 1.04 (Receivables 897.0m/812.0m, Revenue 5.50b/5.19b) |
| GMI: 0.99 (GM 59.95% / 59.60%) |
| AQI: 0.88 (AQ_t 0.52 / AQ_t-1 0.59) |
| SGI: 1.06 (Revenue 5.50b / 5.19b) |
| TATA: -0.02 (NI 940.0m - CFO 1.08b) / TA 7.69b) |
| Beneish M-Score: -3.04 (Cap -4..+1) = AA |
What is the price of VLTO shares?
As of February 27, 2026, the stock is trading at USD 94.37 with a total of 1,973,953 shares traded.
Over the past week, the price has changed by +4.30%, over one month by -3.80%, over three months by -3.08% and over the past year by -1.25%.
Over the past week, the price has changed by +4.30%, over one month by -3.80%, over three months by -3.08% and over the past year by -1.25%.
Is VLTO a buy, sell or hold?
Veralto has received a consensus analysts rating of 3.83.
Therefore, it is recommended to buy VLTO.
- StrongBuy: 6
- Buy: 3
- Hold: 9
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the VLTO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 110.1 | 16.7% |
| Analysts Target Price | 110.1 | 16.7% |
VLTO Fundamental Data Overview February 21, 2026
P/E Trailing = 24.9947
P/E Forward = 26.5957
P/S = 4.2404
P/B = 7.5129
P/EG = 3.7486
Revenue TTM = 5.50b USD
EBIT TTM = 1.27b USD
EBITDA TTM = 1.35b USD
Long Term Debt = 1.97b USD (from longTermDebt, two quarters ago)
Short Term Debt = 700.0m USD (from shortTermDebt, last quarter)
Debt = 2.67b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 642.0m USD (from netDebt column, last quarter)
Enterprise Value = 23.98b USD (23.33b + Debt 2.67b - CCE 2.03b)
Interest Coverage Ratio = 13.22 (Ebit TTM 1.27b / Interest Expense TTM 96.0m)
EV/FCF = 23.65x (Enterprise Value 23.98b / FCF TTM 1.01b)
FCF Yield = 4.23% (FCF TTM 1.01b / Enterprise Value 23.98b)
FCF Margin = 18.43% (FCF TTM 1.01b / Revenue TTM 5.50b)
Net Margin = 17.08% (Net Income TTM 940.0m / Revenue TTM 5.50b)
Gross Margin = 59.95% ((Revenue TTM 5.50b - Cost of Revenue TTM 2.20b) / Revenue TTM)
Gross Margin QoQ = 59.31% (prev 60.11%)
Tobins Q-Ratio = 3.12 (Enterprise Value 23.98b / Total Assets 7.69b)
Interest Expense / Debt = 0.75% (Interest Expense 20.0m / Debt 2.67b)
Taxrate = 13.31% (39.0m / 293.0m)
NOPAT = 1.10b (EBIT 1.27b * (1 - 13.31%))
Current Ratio = 1.67 (Total Current Assets 3.43b / Total Current Liabilities 2.06b)
Debt / Equity = 0.86 (Debt 2.67b / totalStockholderEquity, last quarter 3.11b)
Debt / EBITDA = 0.48 (Net Debt 642.0m / EBITDA 1.35b)
Debt / FCF = 0.63 (Net Debt 642.0m / FCF TTM 1.01b)
Total Stockholder Equity = 2.73b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.33% (Net Income 940.0m / Total Assets 7.69b)
RoE = 34.47% (Net Income TTM 940.0m / Total Stockholder Equity 2.73b)
RoCE = 27.01% (EBIT 1.27b / Capital Employed (Equity 2.73b + L.T.Debt 1.97b))
RoIC = 20.92% (NOPAT 1.10b / Invested Capital 5.26b)
WACC = 7.63% (E(23.33b)/V(26.01b) * Re(8.43%) + D(2.67b)/V(26.01b) * Rd(0.75%) * (1-Tc(0.13)))
Discount Rate = 8.43% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.83%
[DCF] Terminal Value 79.49% ; FCFF base≈936.4m ; Y1≈937.2m ; Y5≈994.2m
[DCF] Fair Price = 73.28 (EV 18.84b - Net Debt 642.0m = Equity 18.19b / Shares 248.3m; r=7.63% [WACC]; 5y FCF grow -0.46% → 2.90% )
EPS Correlation: 92.25 | EPS CAGR: 11.63% | SUE: 3.65 | # QB: 2
Revenue Correlation: 95.11 | Revenue CAGR: 4.77% | SUE: -0.48 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.00 | Chg7d=-0.004 | Chg30d=-0.014 | Revisions Net=+0 | Analysts=14
EPS current Year (2026-12-31): EPS=4.19 | Chg7d=+0.003 | Chg30d=+0.011 | Revisions Net=+5 | Growth EPS=+7.3% | Growth Revenue=+6.2%
EPS next Year (2027-12-31): EPS=4.55 | Chg7d=-0.003 | Chg30d=-0.000 | Revisions Net=+3 | Growth EPS=+8.7% | Growth Revenue=+5.3%
[Analyst] Revisions Ratio: +0.00 (3 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.4% (Discount Rate 8.4% - Earnings Yield 4.0%)
[Growth] Growth Spread = +0.7% (Analyst 5.2% - Implied 4.4%)
P/E Forward = 26.5957
P/S = 4.2404
P/B = 7.5129
P/EG = 3.7486
Revenue TTM = 5.50b USD
EBIT TTM = 1.27b USD
EBITDA TTM = 1.35b USD
Long Term Debt = 1.97b USD (from longTermDebt, two quarters ago)
Short Term Debt = 700.0m USD (from shortTermDebt, last quarter)
Debt = 2.67b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 642.0m USD (from netDebt column, last quarter)
Enterprise Value = 23.98b USD (23.33b + Debt 2.67b - CCE 2.03b)
Interest Coverage Ratio = 13.22 (Ebit TTM 1.27b / Interest Expense TTM 96.0m)
EV/FCF = 23.65x (Enterprise Value 23.98b / FCF TTM 1.01b)
FCF Yield = 4.23% (FCF TTM 1.01b / Enterprise Value 23.98b)
FCF Margin = 18.43% (FCF TTM 1.01b / Revenue TTM 5.50b)
Net Margin = 17.08% (Net Income TTM 940.0m / Revenue TTM 5.50b)
Gross Margin = 59.95% ((Revenue TTM 5.50b - Cost of Revenue TTM 2.20b) / Revenue TTM)
Gross Margin QoQ = 59.31% (prev 60.11%)
Tobins Q-Ratio = 3.12 (Enterprise Value 23.98b / Total Assets 7.69b)
Interest Expense / Debt = 0.75% (Interest Expense 20.0m / Debt 2.67b)
Taxrate = 13.31% (39.0m / 293.0m)
NOPAT = 1.10b (EBIT 1.27b * (1 - 13.31%))
Current Ratio = 1.67 (Total Current Assets 3.43b / Total Current Liabilities 2.06b)
Debt / Equity = 0.86 (Debt 2.67b / totalStockholderEquity, last quarter 3.11b)
Debt / EBITDA = 0.48 (Net Debt 642.0m / EBITDA 1.35b)
Debt / FCF = 0.63 (Net Debt 642.0m / FCF TTM 1.01b)
Total Stockholder Equity = 2.73b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.33% (Net Income 940.0m / Total Assets 7.69b)
RoE = 34.47% (Net Income TTM 940.0m / Total Stockholder Equity 2.73b)
RoCE = 27.01% (EBIT 1.27b / Capital Employed (Equity 2.73b + L.T.Debt 1.97b))
RoIC = 20.92% (NOPAT 1.10b / Invested Capital 5.26b)
WACC = 7.63% (E(23.33b)/V(26.01b) * Re(8.43%) + D(2.67b)/V(26.01b) * Rd(0.75%) * (1-Tc(0.13)))
Discount Rate = 8.43% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.83%
[DCF] Terminal Value 79.49% ; FCFF base≈936.4m ; Y1≈937.2m ; Y5≈994.2m
[DCF] Fair Price = 73.28 (EV 18.84b - Net Debt 642.0m = Equity 18.19b / Shares 248.3m; r=7.63% [WACC]; 5y FCF grow -0.46% → 2.90% )
EPS Correlation: 92.25 | EPS CAGR: 11.63% | SUE: 3.65 | # QB: 2
Revenue Correlation: 95.11 | Revenue CAGR: 4.77% | SUE: -0.48 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.00 | Chg7d=-0.004 | Chg30d=-0.014 | Revisions Net=+0 | Analysts=14
EPS current Year (2026-12-31): EPS=4.19 | Chg7d=+0.003 | Chg30d=+0.011 | Revisions Net=+5 | Growth EPS=+7.3% | Growth Revenue=+6.2%
EPS next Year (2027-12-31): EPS=4.55 | Chg7d=-0.003 | Chg30d=-0.000 | Revisions Net=+3 | Growth EPS=+8.7% | Growth Revenue=+5.3%
[Analyst] Revisions Ratio: +0.00 (3 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.4% (Discount Rate 8.4% - Earnings Yield 4.0%)
[Growth] Growth Spread = +0.7% (Analyst 5.2% - Implied 4.4%)